JAD Promoted at AAIC

Prize Presentation and Overview

JAD and its sister publication JAD Reports were on show at the recent AAIC meeting in Los Angeles. We were pleased to have so many delegates visit our booth to "Meet the Editor", as well as pick-up the reprints of the winning paper of the 2019 Alzheimer Award (sponsored by Memory Health) and the walnut study (the healthy snack giveaway was sponsored by the California Walnut Commission). For those who entered our draw to win a free online subscription to JAD, the winner will be contacted this month.

Board Presentation

Being in Los Angeles for AAIC was also an opportunity to hold an Editorial Board meeting and it was great to see so many of our board members, who work tirelessly to make JAD the success that it is, in attendance. During the meeting, we were very pleased to make the presentation to Weiyi Zeng (pictured with Editor-in-Chief George Perry) on behalf of the 2019 Alzheimer Award recipients: Yan-Jiang Wang and Xian-Le Bu.

In order to keep our JAD editors, authors, and readers informed of JAD's progress and development, we are pleased to now share the 2019 editorial update. To view the presentation, click here (PDF). This includes a wealth of highlights and statistics, including the most-viewed papers, the most popular press releases, and interesting journal statistics such as the turnaround times and submission rates. To discover the milestones that have led to JAD becoming a vehicle for more papers on AD than any other journal, and receiving more citations than any other AD-focused journal, delve into the detailed presentation. We wish to thank our authors and editors for their continued support! For questions or feedback contact us at: editorial@j-alz.com.

Click here to view the 2019 JAD Editorial Update

JAD CME: Take the Quiz Online!

JAD launched a new partnership with Advanced Continuing Education Association (ACEA) last month to provide a new series of fully accredited continuing medical education (CME) journal articles. The JAD CME program, accredited by the ACCME and open to US physicians, launches with 10 landmark articles that have been published in JAD, each with a corresponding CME post-test providing 1.0 AMA PRA Category I Credit™. The catalog of currently available CME articles are all open access and cover a broad range of important topics in AD. Articles will be added on an ongoing basis. In our mailings, we will be highlighting the JAD CME articles and the first one is listed below.

More details at: j-alz.com/cme-credits

Summary: This review provides an overview of clinical trials for AD. A systematic approach to drug development advancing the scientific understanding of the candidate molecule from preclinical studies through clinical trials can increase the probability of success and de-risk development programs. Biomarkers for diagnosis, target engagement and proof-of-pharmacology, outcome assessment, and side effect monitoring assist in drug development.

Upcoming Event

Conference on Alzheimer's Drug Discovery

Sep 16–17, 2019 | Jersey City, NJ, USA

The 20th International Conference on Alzheimer’s Drug Discovery will be held September 16–17, 2019 in Jersey City, NJ, USA. The event will bring together leading researchers developing innovative treatments and cutting-edge diagnostic approaches for Alzheimer’s disease, related dementias and cognitive aging. The conference is organized by the Alzheimer's Drug Discovery Foundation. For more details, visit the website here.

REGISTER NOW: Early Bird Deadline Aug 16, 2019